Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Generic Partners is a leading international pharmaceutical group specializing in the development, registration, and supply of high-quality generic medicines. Headquartered in Australia with key operations in Singapore and India, the company manages an extensive portfolio of finished dosage forms across diverse therapeutic areas, including oncology, cardiology, and the central nervous system. Generic Partners utilizes a strategic business model that combines internal regulatory and formulation expertise with a global network of manufacturing and distribution partners. By focusing on complex generics and value-added formulations, the company provides cost-effective healthcare solutions to markets in the Asia-Pacific region, Canada, and Europe. Their end-to-end service model covers the entire product lifecycle from initial identification to commercial launch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Generic Partners.